130 related articles for article (PubMed ID: 10663669)
1. [Apoptosis and proliferation in the bone marrow of chronic myeloproliferative disorders--biological and prognostic importance].
Kvasnicka HM; Thiele J
Pathologe; 2000 Jan; 21(1):55-62. PubMed ID: 10663669
[TBL] [Abstract][Full Text] [Related]
2. CD34+ stem cells in chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic turnover index in reactive and neoplastic bone marrow lesions: quantification by apoptosis and PCNA labeling.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Scholz S; Erdmann A; Flucke U; Diehl V; Fischer R
Ann Hematol; 1997; 75(1-2):33-9. PubMed ID: 9322681
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors and survival in chronic myeloproliferative disorders].
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):63-72. PubMed ID: 10663670
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
6. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
[TBL] [Abstract][Full Text] [Related]
7. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
[TBL] [Abstract][Full Text] [Related]
8. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R
J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
[TBL] [Abstract][Full Text] [Related]
10. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
11. The chronic myeloproliferative disorders: clonality and clinical heterogeneity.
Spivak JL
Semin Hematol; 2004 Apr; 41(2 Suppl 3):1-5. PubMed ID: 15190515
[TBL] [Abstract][Full Text] [Related]
12. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.
Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482
[TBL] [Abstract][Full Text] [Related]
13. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
16. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
Bartl R; Frisch B; Wilmanns W
Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
Thiele J; Kvasnicka HM; Diehl V; Fischer R; Michiels J
Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of monoclonal B-cell infiltrate in chronic myeloproliferative disorders.
Pajor L; Lacza A; Kereskai L; Jáksó P; Egyed M; Iványi JL; Radványi G; Dombi P; Pál K; Losonczy H
Mod Pathol; 2004 Dec; 17(12):1521-30. PubMed ID: 15257312
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cells in myeloproliferative disorders.
Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
Kvasnicka HM; Thiele J; Regn C; Zankovich R; Diehl V; Fischer R
Ann Hematol; 1999 Feb; 78(2):65-72. PubMed ID: 10089020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
